QXMédical licenses bioresorbable embolic technology from U of MN

Image: QXMédical acquired the world-wide exclusive rights to the bioresorbable embolic technology. Photo: Courtesy of rawpixel from Pixabay.



Related Article
Recommended Whitepaper

View More